EUVIMEDEUVIMED entdecken
Crossref

YTHDC1 Overexpression Inhibits Inflammation and Promotes Autophagy to Ameliorate Ulcerative Colitis Through the XBP1/AMPK/mTOR Pathway

Lijun Meng, Yanli Zhu iD, Lanfang Zhang, Lu Yang, Daiyuan Dong, Fang Yang, Xiaohe Guo iD

Journal of Biochemical and Molecular Toxicology · 2025

DOI: 10.1002/jbt.70434 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Lijun Meng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Henan Medical University, Xinxiang, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, X-Box Binding Protein 1, TOR Serine-Threonine Kinases, Autophagy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: This study was supported by the Henan Medical Science and Technology Research Project (LHGJ20210539)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a chronic inflammatory bowel disease that affects 5 million people globally. YTH N6‐methyladenosine RNA binding protein C (YTHDC1) is a critical regulator in various biological processes, yet its role in UC remains undefined. This study aims to investigate the regulatory function of YTHDC1 in UC pathogenesis. An in vivo UC model was established in C57BL/6 mice using 3% dextran sulfate sodium (DSS). To establish an in vitro UC model, Caco‐2 cells were exposed to 10 μg/mL lipopolysaccharide (LPS). Quantitative real‐time PCR (qRT‐PCR) was employed to detect mRNA expression levels of YTHDC1 and X‐box binding protein 1 (XBP1). Protein expression was analyzed by Western blot analysis assay. Haematoxylin and eosin staining was used to assess colonic pathology. Enzyme‐linked immunosorbent assay was performed to measure the levels of TNF‐α, IL‐6, and IL‐1β. Immunohistochemistry assay was used to determine the LC3II‐positive expression rate. m6A methylated RNA immunoprecipitation assay and RNA immunoprecipitation assay were used to analyze the association between YTHDC1 and XBP1. An actinomycin D assay was performed to evaluate the effect of YTHDC1 overexpression on XBP1 mRNA stability. The study showed YTHDC1 and XBP1 expression were downregulated in colonic tissues from UC patients. Overexpression of YTHDC1 increased colon length and body weight in DSS‐induced mice and inhibited DSS‐triggered production of TNF‐α, IL‐6, and IL‐1β. Additionally, the upregulation of YTHDC1 counteracted the suppressive impact of DSS treatment on autophagy in colon tissues. In Caco‐2 cells, LPS treatment promoted TNF‐α, IL‐6, and IL‐1β production, whereas these effects were attenuated after YTHDC1 overexpression. Moreover, LPS‐induced Caco‐2 cells showed decreases in the ratio of LC3II to LC3I and beclin1 protein expression and an increase in P62 protein expression, however, YTHDC1 overexpression relieved these effects. In addition, the results showed that the treatment with AMPK inhibit or attenuated YTHDC1 overexpression‐induced effects in LPS‐treated Caco‐2 cells. Furthermore, YTHDC1 was found to stabilize the expression of XBP1 and activate the AMPK/mTOR pathway. Thus, YTHDC1 overexpression inhibited inflammation and promoted autophagy to ameliorate UC through the XBP1/AMPK/mTOR pathway. These findings highlight YTHDC1 as apotential therapeutic target for UC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeX-Box Binding Protein 1TOR Serine-Threonine KinasesAutophagyAMP-Activated Protein KinasesInflammationSignal TransductionRNA-Binding ProteinsAnimalsHumansMiceMice, Inbred C57BLCaco-2 CellsMaleDextran Sulfate

Stichwörter der Autor:innen

AMPK/mTOR pathwayXBP1YTHDC1ulcerative colitis

Substanzen

X-Box Binding Protein 1TOR Serine-Threonine KinasesAMP-Activated Protein KinasesXBP1 protein, humanRNA-Binding ProteinsXbp1 protein, mouseMTOR protein, humanmTOR protein, mouseDextran Sulfate

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Affiliated Hospital of Henan Medical University, Xinxiang, China.

ORCID-Profile: Yanli Zhu, Xiaohe Guo

Förderung

  • This study was supported by the Henan Medical Science and Technology Research Project (LHGJ20210539).

Zitieren

APA

Meng, L., Zhu, Y., Zhang, L., Yang, L., Dong, D., Yang, F., & Guo, X. (2025). YTHDC1 Overexpression Inhibits Inflammation and Promotes Autophagy to Ameliorate Ulcerative Colitis Through the XBP1/AMPK/mTOR Pathway. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70434

Vancouver

Meng L, Zhu Y, Zhang L, Yang L, Dong D, Yang F, et al. YTHDC1 Overexpression Inhibits Inflammation and Promotes Autophagy to Ameliorate Ulcerative Colitis Through the XBP1/AMPK/mTOR Pathway. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70434

BibTeX
@article{Meng2025,
  author = {Meng, Lijun and Zhu, Yanli and Zhang, Lanfang and Yang, Lu and Dong, Daiyuan and Yang, Fang and Guo, Xiaohe},
  title = {YTHDC1 Overexpression Inhibits Inflammation and Promotes Autophagy to Ameliorate Ulcerative Colitis Through the XBP1/AMPK/mTOR Pathway},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  doi = {10.1002/jbt.70434}
}
Kostenlos starten →